Home page

Manufacturing
Research and development
Global Disease Initiative
Investor relations
Strides world wide
Products
Press room

Careers
Contact us
Sitemap
Search

Investor relations

Strides Group
  Key Data
    Profit & Loss
    Balance Sheet
    Cash-flow
    Employee

Corporate Governance
  Board of Directors 
  Board Committees
  Management
  Code of Conduct
  Company History

Shares
  Share Price
  Share Chart
  Historic Share Price 

Financials
  Quarterly Results
  Annual Reports 
  Presentations 

Manufacturing resources

  Softgel capsules
  Steriles
  Specialty chemicals

Global Disease Initiative

Anti-tuberculosis products
Anti-retroviral drugs
Anti-malarial drugs

Products

ORAL DOSAGE FOR
Immunosuppressants
Anti-retroviral drugs
Anti-tuberculosis products
Anti-malarial drugs
Antibiotics and anti-infectives
Other anti-infectives
Anti –anginal & anti- hypertensive drugs Hypolipidaemic Agents (Cholesterol Reducing Agents)
Gastrointestinal Agents
Anti-emetics
NSAIDs /Analgesics
Steroids and Hormones
Anti-allergic drugs
Vitamins/Minerals and Calcium regulators

STERILE PRODUCTS
Immunosuppressant
Anti-tuberculosis agents
Anti-malarial
Antibiotics and anti-infectives
Steroids and Hormones
Antispasmodic/ muscle relaxants
Gastrointestinal Agents

BETA LACTAMS
Beta Lactams

CEPHALOSPORINS
Cephalosporins

Press room

  Latest news
  Archives
  Media resources
  Press kit
  Strides profile